Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment: study protocol for the ReScreen randomized controlled trial.
Breast cancer
Individualization
RCT
Rehabilitation
Screening
Sickness absence
Symptom distress
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
29 May 2020
29 May 2020
Historique:
received:
09
01
2020
accepted:
01
04
2020
entrez:
31
5
2020
pubmed:
31
5
2020
medline:
12
1
2021
Statut:
epublish
Résumé
It is well known that women suffer from negative consequences following breast cancer (BC) treatment and that their largely varying needs for rehabilitation are often unmet. Up to 43% of these women are at risk of developing chronic distress requiring complex interventions; however, how to early identify and meet these women's needs is unknown, leaving them with suboptimal chances of rehabilitation. The aim of the ReScreen study is to develop a model for and evaluate the effect of screening-based, individualized rehabilitation following primary BC treatment. The ReScreen study is designed as a complex intervention. Women with newly diagnosed BC are consecutively included in a three-armed randomized controlled trial. At inclusion, patients score their distress level on the Distress Thermometer (scale of 0-10) aiming to identify patients with extended rehabilitation needs. Patients scoring ≥5 are randomized to the intervention or control group while patients scoring ≤4 are followed longitudinally as an observational group. Patients in the intervention group, in conjunction with a dedicated research nurse, create an individualized rehabilitation plan based on an evidence-based decision support tool that was developed to create a solid base for the intervention. The research nurse will act as a continuous health care contact and be responsible for proactively and systematically evaluating patients' needs to ensure that potential new problems or changed rehabilitation needs are identified throughout the 1-year follow-up period. The intervention will be evaluated through self-reported data focusing on physical and psychological outcomes as well as evaluation of satisfaction with care at baseline, 2 weeks and 3, 6, 9 and 12 months. Evaluation will also include health economic aspects based on register data and patients' and relatives' experiences of the rehabilitation process. In addition, optimal cut-off levels for distress as an indicator for extended rehabilitation needs will be investigated. This study will provide important knowledge related to effectiveness of screening-based identification of rehabilitation needs and standardized evidence-based, individualized rehabilitation after primary BC treatment. With a complex intervention design, this study has the potential to form a comprehensive knowledge base which includes tools and guidelines for implementation into clinical practice. ClinicalTrials.gov NCT03434717. Registered February 15, 2018.
Sections du résumé
BACKGROUND
BACKGROUND
It is well known that women suffer from negative consequences following breast cancer (BC) treatment and that their largely varying needs for rehabilitation are often unmet. Up to 43% of these women are at risk of developing chronic distress requiring complex interventions; however, how to early identify and meet these women's needs is unknown, leaving them with suboptimal chances of rehabilitation. The aim of the ReScreen study is to develop a model for and evaluate the effect of screening-based, individualized rehabilitation following primary BC treatment.
METHODS
METHODS
The ReScreen study is designed as a complex intervention. Women with newly diagnosed BC are consecutively included in a three-armed randomized controlled trial. At inclusion, patients score their distress level on the Distress Thermometer (scale of 0-10) aiming to identify patients with extended rehabilitation needs. Patients scoring ≥5 are randomized to the intervention or control group while patients scoring ≤4 are followed longitudinally as an observational group. Patients in the intervention group, in conjunction with a dedicated research nurse, create an individualized rehabilitation plan based on an evidence-based decision support tool that was developed to create a solid base for the intervention. The research nurse will act as a continuous health care contact and be responsible for proactively and systematically evaluating patients' needs to ensure that potential new problems or changed rehabilitation needs are identified throughout the 1-year follow-up period. The intervention will be evaluated through self-reported data focusing on physical and psychological outcomes as well as evaluation of satisfaction with care at baseline, 2 weeks and 3, 6, 9 and 12 months. Evaluation will also include health economic aspects based on register data and patients' and relatives' experiences of the rehabilitation process. In addition, optimal cut-off levels for distress as an indicator for extended rehabilitation needs will be investigated.
DISCUSSION
CONCLUSIONS
This study will provide important knowledge related to effectiveness of screening-based identification of rehabilitation needs and standardized evidence-based, individualized rehabilitation after primary BC treatment. With a complex intervention design, this study has the potential to form a comprehensive knowledge base which includes tools and guidelines for implementation into clinical practice.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT03434717. Registered February 15, 2018.
Identifiants
pubmed: 32471390
doi: 10.1186/s12885-020-06815-3
pii: 10.1186/s12885-020-06815-3
pmc: PMC7257149
doi:
Banques de données
ClinicalTrials.gov
['NCT03434717']
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
484Références
BMC Health Serv Res. 2020 Mar 26;20(1):252
pubmed: 32216786
Ann Oncol. 2016 Jun;27(6):965-74
pubmed: 26940687
Cancer Nurs. 2017 May/Jun;40(3):E35-E40
pubmed: 27135753
Asia Pac J Clin Oncol. 2017 Apr;13(2):e79-e95
pubmed: 25560636
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
Scand J Caring Sci. 2007 Jun;21(2):229-37
pubmed: 17559442
CA Cancer J Clin. 2016 Jul;66(4):271-89
pubmed: 27253694
Health Qual Life Outcomes. 2011 Feb 04;9:8
pubmed: 21294858
Breast. 2017 Dec;36:89-95
pubmed: 28988610
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Breast Cancer Res Treat. 2019 Aug;176(3):519-533
pubmed: 31087199
Acta Oncol. 2017 Feb;56(2):314-320
pubmed: 28093034
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Support Care Cancer. 2013 Sep;21(9):2469-76
pubmed: 23604453
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
J Natl Cancer Inst. 2012 Mar 7;104(5):386-405
pubmed: 22271773
Breast. 2017 Jun;33:166-177
pubmed: 28415013
Acta Oncol. 2013 Feb;52(2):391-9
pubmed: 23244672
J Natl Compr Canc Netw. 2013 Feb 1;11(2):190-209
pubmed: 23411386
Pain Manag Nurs. 2013 Jun;14(2):110-23
pubmed: 23688365
BMC Cancer. 2019 May 20;19(1):472
pubmed: 31109309
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Eur J Oncol Nurs. 2018 Apr;33:70-77
pubmed: 29551180
Psychooncology. 2014 Apr;23(4):361-74
pubmed: 24677334
J Clin Oncol. 1996 Oct;14(10):2756-68
pubmed: 8874337
Eur J Oncol Nurs. 2014 Jun;18(3):242-53
pubmed: 24485012
Support Care Cancer. 2012 Apr;20(4):741-7
pubmed: 21479789
Qual Life Res. 2004 Feb;13(1):191-206
pubmed: 15058800
J Natl Compr Canc Netw. 2018 Aug;16(8):959-966
pubmed: 30099372
J Multidiscip Healthc. 2017 Aug 30;10:347-357
pubmed: 28919774
J Clin Oncol. 2012 Apr 10;30(11):1160-77
pubmed: 22412146
Support Care Cancer. 2017 Mar;25(3):709-718
pubmed: 27873016
J Cancer Surviv. 2015 Dec;9(4):620-9
pubmed: 25708515
Cancer. 2012 Apr 15;118(8 Suppl):2217-25
pubmed: 22488696
Psychooncology. 2012 Apr;21(4):436-43
pubmed: 21280139
Eur J Oncol Nurs. 2012 Sep;16(4):439-43
pubmed: 22036771
Acta Oncol. 2013 Feb;52(2):372-81
pubmed: 23320774
Eur J Oncol Nurs. 2013 Oct;17(5):625-31
pubmed: 23343788
Acta Oncol. 2013 Feb;52(2):382-90
pubmed: 23320775
J Clin Med Res. 2017 Oct;9(10):864-871
pubmed: 28912923